46 related articles for article (PubMed ID: 34039789)
1. Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis.
Ghosal S; Hadrava Vanova K; Uher O; Das S; Patel M; Meuter L; Huynh TT; Jha A; Talvacchio S; Knue M; Prodanov T; Zeiger MA; Nilubol N; Taieb D; Crona J; Shankavaram UT; Pacak K
Endocrine; 2023 Jan; 79(1):171-179. PubMed ID: 36370152
[TBL] [Abstract][Full Text] [Related]
2. Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma.
Saddozai UAK; Wang F; Akbar MU; Zhang L; An Y; Zhu W; Xie L; Li Y; Ji X; Guo X
Front Endocrinol (Lausanne); 2021; 12():605797. PubMed ID: 34234737
[TBL] [Abstract][Full Text] [Related]
3. Targeted molecular medicine: advances in the treatment of metastatic phaeochromocytoma and paraganglioma.
Naruse M; Young WF
Lancet; 2024 Mar; 403(10431):1001-1003. PubMed ID: 38402884
[No Abstract] [Full Text] [Related]
4. From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response.
Elsakka EGE; Elshafei A; Elkady MA; Yehia AM; Abulsoud AI; Shahin RK; Abdelmaksoud NM; Elkhawaga SY; Ismail A; Mokhtar MM; Elrebehy MA; Hegazy M; Elballal MS; Mohammed OA; Abdel-Reheim MA; El-Dakroury WA; Abdel Mageed SS; El-Mahdy HA; Doghish AS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):1957-1969. PubMed ID: 37801146
[TBL] [Abstract][Full Text] [Related]
5. Adrenal pheochromocytoma impacts three main pathways: cysteine-methionine, pyrimidine, and tyrosine metabolism.
Lai C; Yang Q; Zhang Y; Gong R; Wang M; Li J; Lai M; Sun Q
J Zhejiang Univ Sci B; 2024 Mar; 25(5):410-421. PubMed ID: 38725340
[TBL] [Abstract][Full Text] [Related]
6. Screening and Identification of Key Biomarkers in Lower Grade Glioma via Bioinformatical Analysis.
Guo F; Yan J; Ling G; Chen H; Huang Q; Mu J; Mo L
Appl Bionics Biomech; 2022; 2022():6959237. PubMed ID: 35035531
[TBL] [Abstract][Full Text] [Related]
7. Core needle biopsy in pheochromocytoma/paraganglioma: should it be considered?
Huszty G; Igaz P
Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 38031993
[No Abstract] [Full Text] [Related]
8. Constructing a Novel Amino Acid Metabolism Signature: A New Perspective on Pheochromocytoma Diagnosis, Immune Landscape, and Immunotherapy.
Yan Z; Luan Y; Wang Y; Ren Y; Li Z; Zhao L; Shen L; Yang X; Liu T; Gao Y; Sun W
Biochem Genet; 2024 Mar; ():. PubMed ID: 38526709
[TBL] [Abstract][Full Text] [Related]
9. Response to Letter to the Editor regarding 'Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma'.
Zhang L; Åkerström T; Mollazadegan K; Beuschlein F; Pacak K; Skogseid B; Crona J
Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 38031994
[No Abstract] [Full Text] [Related]
10. Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients.
Seamon ML; Yamaguchi I
Curr Hypertens Rep; 2021 May; 23(5):32. PubMed ID: 34041599
[TBL] [Abstract][Full Text] [Related]
11. SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
Jiang P; Cao Y; Gao F; Sun W; Liu J; Ma Z; Xie M; Fu S
BMC Cancer; 2021 Jun; 21(1):694. PubMed ID: 34116656
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer.
Chen S; Gao C; Yu T; Qu Y; Xiao GG; Huang Z
Front Oncol; 2021; 11():641289. PubMed ID: 34094925
[TBL] [Abstract][Full Text] [Related]
13. Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data.
Choi YM; Lim J; Jeon MJ; Lee YM; Sung TY; Hong EG; Lee JY; Jang SJ; Kim WG; Song DE; Chun SM
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069252
[TBL] [Abstract][Full Text] [Related]
14. AKR1B1 Represses Glioma Cell Proliferation through p38 MAPK-Mediated Bcl-2/BAX/Caspase-3 Apoptotic Signaling Pathways.
Huang YK; Chang KC; Li CY; Lieu AS; Lin CL
Curr Issues Mol Biol; 2023 Apr; 45(4):3391-3405. PubMed ID: 37185746
[TBL] [Abstract][Full Text] [Related]
15. miR-425 regulates lipophagy via SIRT1 to promote sorafenib resistance in liver cancer.
Sun G; Yang L; Wei S; Jin H; Li B; Li H
Oncol Lett; 2021 Oct; 22(4):695. PubMed ID: 34457050
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analysis of differentially expressed genes as prognostic markers in pheochromocytoma and paraganglioma tumors.
Shi Z; Kong X; Li C; Liu H; Aliagan AI; Liu L; Shi Y; Shi X; Ma B; Jin R; Wang S; Pan D; Tang J
Genes Genet Syst; 2021 Jul; 96(2):55-69. PubMed ID: 34039789
[TBL] [Abstract][Full Text] [Related]
17. Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis.
Chen CX; Chen DN; Sun XL; Ke ZB; Lin F; Chen H; Tao X; Huang F; Wei Y; Xu N
Aging (Albany NY); 2021 Mar; 13(7):9976-9990. PubMed ID: 33795528
[TBL] [Abstract][Full Text] [Related]
18. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
19. Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker.
Ghosal S; Das S; Pang Y; Gonzales MK; Huynh TT; Yang Y; Taieb D; Crona J; Shankavaram UT; Pacak K
Int J Cancer; 2020 Apr; 146(8):2326-2335. PubMed ID: 31469413
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
